CEL-SCI (STU:LSRM) Net Change in Cash : €-4.39 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is CEL-SCI Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

CEL-SCI's Net Change in Cash for the three months ended in Mar. 2024 was €1.90 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was €-4.39 Mil.

CEL-SCI Net Change in Cash Historical Data

The historical data trend for CEL-SCI's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CEL-SCI Net Change in Cash Chart

CEL-SCI Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Net Change in Cash

Get a 7-Day Free Trial

-1.69

6.00

17.47

-13.52

-17.36

CEL-SCI Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-7.44	-4.53	-0.93	-0.83	1.90

CEL-SCI Net Change in Cash Calculation

CEL-SCI's Net Change in Cash for the fiscal year that ended in Sep. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-21.41	+	-0.349	+	4.398	+	0
	=	-17.36

CEL-SCI's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -4.166 + 0 + 6.068 + 0

= 1.90

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-4.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CEL-SCI Net Change in Cash Related Terms
Thank you for viewing the detailed overview of CEL-SCI's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

CEL-SCI (STU:LSRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CEL-SCI Corp (STU:LSRM) » Definitions » Net Change in Cash

Comparable Companies

CRIS CLGN VTVT LTRN MNOV AVRO CKPT RLYB IKNA INTS OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX

Traded in Other Exchanges

CVM:USA LSRM:Germany

Address

8229 Boone Boulevard, Suite 802, Vienna, VA, USA, 22182

Website

https://www.cel-sci.com

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

CEL-SCI (STU:LSRM) Headlines

No Headlines